These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9621406)

  • 1. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.
    Ni Y; Marchal G
    Top Magn Reson Imaging; 1998 Jun; 9(3):183-95. PubMed ID: 9621406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.
    Ni Y; Marchal G; Yu J; Mühler A; Lukito G; Baert AL
    J Magn Reson Imaging; 1994; 4(3):355-63. PubMed ID: 8061434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
    J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.
    Channual S; Pahwa A; Lu DS; Raman SS
    Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
    Martin DR; Semelka RC; Chung JJ; Balci NC; Wilber K
    Magn Reson Imaging; 2000 Oct; 18(8):955-63. PubMed ID: 11121698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Invest Radiol; 2012 Nov; 47(11):649-55. PubMed ID: 23011189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
    Ni Y; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
    Schmitz SA; Mühler A; Wagner S; Wolf KJ
    Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake.
    Van Beers BE; Grandin C; Pauwels S; Mottet I; Goudemant JF; Delos M; Demeure R; Pringot J
    J Magn Reson Imaging; 1994; 4(3):351-4. PubMed ID: 8061433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
    Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
    Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
    Young SW; Bradley B; Muller HH; Rubin DL
    Magn Reson Imaging; 1990; 8(3):267-76. PubMed ID: 2114511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRI.
    Petré C; Ni Y; Marchal G; Yu J; Wevers M; Lauffer RB; Baert AL
    Magn Reson Med; 1996 Apr; 35(4):532-9. PubMed ID: 8992203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.